Fibroblast Activation Protein (FAP) – A promising target for radiopharmaceuticals Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer June 8, 2022 Download the Presentation sofie_c557hm2025-10-15T16:42:12+00:00June 8th, 2022|Webinars| Share This Story, Choose Your Platform! FacebookXLinkedInPinterest Related Posts Current State of FAP Targeting Radioligands in Oncology Gallery Current State of FAP Targeting Radioligands in Oncology June 18th, 2025 Amyloid Biomarker Imaging and FDG in the Era of an Approved Anti Amyloid Therapy Gallery Amyloid Biomarker Imaging and FDG in the Era of an Approved Anti Amyloid Therapy March 28th, 2025 Imaging Cancer through the Stroma – FAPI PET/CT, a Novel Tracer in Oncology Gallery Imaging Cancer through the Stroma – FAPI PET/CT, a Novel Tracer in Oncology November 9th, 2024 FAPI-PET imaging & theranostics: A new era in targeting cancer and fibrotic diseases Gallery FAPI-PET imaging & theranostics: A new era in targeting cancer and fibrotic diseases November 7th, 2024 FAP Ligands for Imaging and Therapy Gallery FAP Ligands for Imaging and Therapy June 12th, 2022
